Integrated by design
Our ‘Integrated by design’ approach goes far beyond a portfolio.
Our suite of products have been designed and engineered to work seamlessly together, ensuring optimal functionality, and compatibility.
With real-time 3D visualization enabled by the CARTO™ 3 System and the integrated solutions designed to complement it, you have the insights needed for confidence in your outcomes.
The power of partnership
The REAL AF Registry, led by physicians and in collaboration with Biosense Webster, Inc., part of Johnson & Johnson MedTech, was unique to use real-world evidence to expand device labels for an alternative zero fluoroscopy workflow.ii
86%
Freedom from atrial fibrillation at 1 year1
72%
Fluoroless cases1
1.9%
Overall complication rate*1
93%
No arrhythmia symptoms1
Our product innovations are designed to unlock the full potential of your practice.
This integration goes beyond the simple coexistence of different instruments – it is a conscious effort to create a synergistic system that enhances overall performance and outcomes.
An integrated CARTO™ experience
CARTO™ 3 System
Advance your mapping capabilities through tools such as enhanced signal analysis and improved substrate characterization, and utilization of ultrasound technology with CARTO™ V8.2,3
LAT Velocity Vectors (LVV) provides a representation of the activation wave velocity over a substrate map done in sinus rhythm or during pacing.3
Local Velocity Vectors aims to improve the specificity of localizing the most arrhythmogenic regions within the scar and reduce the need to characterize the substrate properties under different activation wavefronts.**,5
The Stability+ algorithm continuously analyzes the overall movement of the ablation catheter, separating the movement due to respiration from the actual catheter movement. This continuous analysis reduces the time for initial indication of stability and the appearance of VISITAG™ Module Sites.***,4
Dr. Saumil Oza
MD, Electrophysiologist
Supporting with excellence
Expertise at your side
Our team of clinical specialists have a deep knowledge in every aspect of the mapping technology to complement your team’s skills and offer real-time insights when you need them.
Training expertise centers
We offer a comprehensive site visit program to physicians and fellows who are interested in observing safe and effective utilization of our current technology during complex ablations in a clinical setting.
Therapy advancement program
With a focus on clear and accessible AFib education, insights from physician thought leaders, and compelling patient stories, Get Smart About AFib aims to be a trusted resource where physicians and providers can confidently refer their patients.
Patient education resources
With a focus on clear and accessible AFib education, insights from physician thought leaders, and compelling patient stories, Get Smart About AFib aims to be a trusted resource where physicians and providers can confidently refer their patients.
Browse products
References
*Most complications were either vascular or pericarditis/effusion. No deaths during follow-up; one atrioesophageal fistula (treated and survived)
**Study includes sixteen patients with ischemic VT, with substrate maps obtained in SR (6), RV pacing (12), and LV Pacing (9). In the 7 patients VT was non-inducible at the end of the procedure. LAVAs were successfully eliminated in 15 of the 16 cases.
***Compared to previous version of CARTO™ 3 System software.
i. Biosense Webster, Inc.’s portfolio of products with FDA approved/cleared instructions for use to support fluoro alternative workflows when used with the CARTO™ 3 System include the following: THERMOCOOL SMARTTOUCH™ SF catheter, THERMOCOOL SMARTTOUCH™ Catheter, CARTO VIZIGO™ Bi-Directional Guiding Sheath, PENTARAY™ NAV ECO High Density Mapping Catheter, DECANAV™ Mapping Catheters, and Webster™ CS Catheter
ii. Change pertains to another way of obtaining evidence and data
- Osorio J, Miranda-Arboleda AF, Velasco A, et al. Real-world data of radiofrequency catheter ablation in paroxysmal atrial fibrillation: Short- and long-term clinical outcomes from the prospective multicenter REAL-AF Registry. Heart Rhythm. 2024;21(11):2083-2091.
- UG-5407-018H - ELEVATE Module Instructions for Use and Release Notes.
- UG-5400-008H - Instructions for Use Software Version 8.1
- UG-5400-798 - CARTO VISITAG™ Module User Guide
- Lima da Silva G et al. Impact of different activation wavefronts on ischemic myocardial scar electrophysiological properties during high‐density ventricular tachycardia mapping and ablation. J Cardiovasc Electrophysiol. 2023 Feb;34(2):389-399.
DO NOT use OCTARAY™ or OPTRELL™ Mapping Catheters with TRUEref™ Technology in patients with prosthetic valves.
The Johnson & Johnson and its affiliates QDOT MICRO™ Catheters and related accessory devices are indicated for catheter-based cardiac electrophysiological mapping (stimulating and recording) and, when used in conjunction with a compatible radiofrequency generator, for the treatment of:
- Type I atrial flutter in patients age 18 or older.
- Drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible three-dimensional electroanatomic mapping systems. The Johnson & Johnson and its affiliates QDOT MICRO™ Catheters provide real-time measurement of contact force between the catheter tip and heart wall, as well as location information when used with CARTO™ 3 Navigation System.
Drs. Amin, Oza and Badin are compensated by and presenting on behalf of Biosense Webster, Inc., and must present information in accordance with applicable regulatory requirements.
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician.
This site is published by Johnson & Johnson and its affiliates, which is solely responsible for its contents. It is intended for visitors from the United States.
US_ELP_NAVI_406486